Language
Español
English
0

Nexera lite inert - Características

NUEVO

Cromatografía líquida de alta resolución

Improved Data Reliability by Preventing System Corrosion from Halogenic Salt

For analysis of antibody drugs or proteins in biological samples,a metal-free LC system is required for good repeatability over a long time due to high-concentration, salt-containing mobile phases such as Sodium chloride. With no metal material in the low path, Nexera lite inert provides stable aggregate assay results with good repeatability.

 

  • Análisis de agregado de anticuerpo de IgG monoclonal mediante cromatografía de exclusión por tamaño
  •  Resultados de la prueba de resistencia a la corrosión del cabezal de la bomba
  • Monoclonal IgG antibody aggregate analysis by gel filtration chromatography
  • Resultados de la prueba de resistencia a la corrosión de los cabezales de la bomba

 

Estabilidad superior del tiempo de retención mediante una suministro de solventes altamente precisa

With the outstanding flow-rate stability, the Nexera lite inert provides excellent retention time repeatability.

Análisis de los agregados en el fármaco con anticuerpo

Análisis de los agregados en el fármaco con anticuerpo (n = 5)

 

Monitoreo en tiempo real del pH de la fase móvil

En la cromatografía de intercambio iónico o de exclusión por tamaño, el pH de la fase móvil a veces afecta la separación de compuestos. El monitor de pH, pHM-40, monitorea y registra continuamente el pH de la fase móvil. Los cromatogramas de pH y detector se guardan dentro del mismo archivo de datos y se pueden superponer, lo que garantiza una rastreabilidad eficiente de los datos.

Configuración del sistema

Analysis of Antibody Drugs by Gel Filtration Chromatography

Antibody Drugs

 

Antibody aggregates indicate the immunogenic potential. In addition, aggregates can result in lower purification efficiency and lower production quantities of antibodies, which are the main active ingredient in antibody drugs. Therefore, antibody drug aggregate analysis is an important process in the manufacturing and quality control of biopharmaceuticals. Using a Nexera lite inert system ensures reliable data can be acquired without worrying about protein adsorption or the risk of corrosion by high salt concentrations.

 

Analysis of Structural Changes in Proteins Using a Fluorescence Detector

Chromatogram of Membrane Protein with GFP Before/After Heat Treatment (Evaluated with Fluorescence Detector)

 

In addition to a general-purpose absorbance detector, Nexera lite inert systems support using a metal-free inert cell with a fluorescence detector, expanding their use to a wider range of applications. The figure on the right is from an example of using gel filtration chromatography to evaluate the molecular weight distribution of heat-treated membrane proteins that contain green fluorescent protein (GFP). It shows that structural changes due to the heat treatment temperature can be detected by fluorescence detection.

Target Compounds Recovered with a Fraction Collector for the Next Analysis Step

Preparative separation of target peaks is possible by connecting an FRC-10A fraction collector to the Nexera lite inert system. The FRC-10A includes no metal materials in low channels, which allows the configuration of systems that are fully inert through to target recovery. In addition, the FRC-10A is compatible with 1.5 mL tubes, 15 mL centrifuge tubes, and 96-well DWPs, so targets can be collected in containers appropriate for subsequent process steps.

Target Compounds Recovered with a Fraction Collector for the Next Analysis Step

 

Purifying and Selectively Recovering Fluorescently Labeled Antibodies

Chromatogram of Phycoerythrin-Labeled Antibodies (Upper: Fluorescence Detector; Lower: Absorbance Detector)

 

Using a combination of multiple detectors and fraction collectors offers the feexibility to purify samples based on the specific characteristics of target compounds. For example, by using both an absorbance detector and fluorescence detector, antibodies with and without fluorescent labeling can be monitored at the same time. Furthermore, by using an FRC-10A fraction collector to ensure reliable preparative separation of only target components, fluorescently labeled antibodies can be used directly in the next process step.

¿Vive en los Estados Unidos?

Visite nuestro sitio web de EE. UU.